The Charles T. Campbell Eye Microbiology Lab
UPMCUniversity of Pittsburgh Schools of the Health Sciences
HomeContact InformationLab Diagnostic TestingAntibiotic SusceptibilityAntimicrobial TherapyCurrent ResearchPhotos


Ocular Microbiology and Immunology Group
Back to OMIG Main Page

< Previous | 2026 Agenda and Abstracts | Next >

 

2026 OMIG Abstract

Persistent Cysts in the Explanted Cornea Predict Graft Failure in Acanthamoeba Keratitis

Felipe Echeverri Tribin1, Helen Song2, Wendy Li3, Brandon Chou4, Jaime Martinez3, Sander Dubovy3, Darlene Miller3,5, and Guillermo Amescua3,5

1Ophthalmic Biophysics Center, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; 2University of Illinois Chicago, Department of Ophthalmology and Visual Sciences, Chicago, Illinois; 3Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida; 4Department of Ophthalmology, Yale School of Medicine, New Haven, Connecticut; 5Ocular Microbiology Laboratory, Department of Ophthalmology, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, Florida

Purpose: To determine whether histopathologic cyst-positivity of the excised cornea predicts graft failure in Acanthamoeba keratitis (AK), and to characterize long-term outcomes.

Methods: A retrospective review was conducted of all patients initially diagnosed with AK at Bascom Palmer Eye Institute (BPEI) from 2015 - 2026. Patients were divided into two groups based on whether their treatment regimen included miltefosine or without. Further subgroups were identified as follows: no corticosteroid use, established corticosteroid use prior to infection, steroids started prior to anti-amoebic therapy, and steroids started after anti-amoebic therapy.

Results: Most patients were contact lens wearers (78%); median age was 49 years and 60% were referred from external providers. Cultures confirmed the diagnosis in 64% of eyes, and corneal histopathology established AK in 11 eyes with non-diagnostic cultures. More than 90% of speciated isolates were A. castellanii (T4 genotype), indicating a microbiologically homogeneous cohort. The competing-risks cumulative incidence of medical cure was 49% at one year, plateauing near 67%, with resolution often protracted (median anti-amoebic therapy, 133 days); approximately one-third of eyes required therapeutic keratoplasty. Penetrating keratoplasty (therapeutic or optical) was performed in 67% of eyes. Among 50 grafts with evaluable follow-up, failure occurred in 13 (26%) and persistent cysts in corneal buttons were strongly associated with failure (53% [8/15] vs 14% [5/35]; HR 4.5, 95% CI 1.5-13.9; log-rank p=0.004). Visual acuity improved overall, from a median of 20/200 to 20/60 (median change -0.37 logMAR; p=0.002).

Conclusions: Corneal histopathology carries both diagnostic and prognostic value in AK. Tissue examination revealed the diagnosis in eyes with non-diagnostic cultures, and persistence of cysts in the excised cornea strongly predicted subsequent graft failure within a genotypically homogeneous cohort. Medical cure was achieved in roughly two-thirds of eyes, though resolution was often prolonged. Two-thirds of eyes underwent keratoplasty. Cyst status at keratoplasty may guide postoperative surveillance, re-grafting decisions, and patient counseling.



Disclosure:
N

Support:

NIH Center Core Grant P30EY014801; Research to Prevent Blindness Unrestricted Grant; Department of Defense


< Previous | 2026 Agenda and Abstracts | Next >

 


 

 

space